KR101016595B1 - 수성액제 및 광안정화된 수성액제 - Google Patents
수성액제 및 광안정화된 수성액제 Download PDFInfo
- Publication number
- KR101016595B1 KR101016595B1 KR1020047010338A KR20047010338A KR101016595B1 KR 101016595 B1 KR101016595 B1 KR 101016595B1 KR 1020047010338 A KR1020047010338 A KR 1020047010338A KR 20047010338 A KR20047010338 A KR 20047010338A KR 101016595 B1 KR101016595 B1 KR 101016595B1
- Authority
- KR
- South Korea
- Prior art keywords
- aqueous liquid
- piperidino
- chlorophenyl
- pyridyl
- methoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
제형물 | 1 | 2 | 3 | 4 | 5 | 6 |
베포타스틴 베실레이트 | 1.5 g | 1.5 g | 1.5 g | 1.5 g | 1.5 g | 1.5 g |
염화나트륨 | - | 0.1 g | 0.2 g | 0.3 g | - | - |
염화칼륨 | - | - | - | - | 0.79 g | - |
염화칼슘 2H2O | - | - | - | - | - | 1.18 g |
수산화나트륨 | 적당량 | 적당량 | 적당량 | 적당량 | 적당량 | 적당량 |
총량 | 100 ㎖ | 100 ㎖ | 100 ㎖ | 100 ㎖ | 100 ㎖ | 100 ㎖ |
pH | 7.0 | 7.0 | 6.7 | 6.9 | 6.7 | 6.8 |
제형물 | 7 | 8 | 9 |
베포타스틴 베실레이트 | 1.5 g | 1.5 g | 1.5 g |
이수소인산나트륨 이수화물 | 0.1 g | - | - |
붕산 | - | 1.0 g | 0.5 g |
염화나트륨 | 0.6 g | - | - |
글리세린 | - | 0.5 g | 2.0 g |
염화벤즈알코늄 | 0.005 g | 0.005 g | 0.005 g |
수산화나트륨 | 적당량 | 적당량 | 적당량 |
총량 | 100 ㎖ | 100 ㎖ | 100 ㎖ |
pH | 6.8 | 6.8 | 6.8 |
제형물 | 10 | 11 | 12 |
베포타스틴 베실레이트 | 1.5 g | 1.5 g | 0.1 g |
이수소인산나트륨 이수화물 | 0.1 g | 0.1 g | 0.1 g |
염화나트륨 | 0.6 g | 0.6 g | 0.82 g |
염화벤즈알코늄 | 0.005 g | 0.005 g | 0.005 g |
수산화나트륨 | 적당량 | 적당량 | 적당량 |
총량 | 100 ㎖ | 100 ㎖ | 100 ㎖ |
pH | 4.0 | 8.5 | 6.8 |
제형물 | 13 | 14 | 15 | 16 | 17 |
베포타스틴 베실레이트 | 0.5 g | 1.0 g | 1.5 g | 1.5 g | 1.5 g |
이수소인산나트륨 이수화물 | 0.1 g | 0.1 g | 0.1 g | 0.1 g | 0.1 g |
글리세린 | 2.2 g | 2.0 g | 1.7 g | 1.7 g | 1.7 g |
염화벤즈알코늄 | 0.005 g | 0.005 g | 0.005 g | 0.005 g | 0.005 g |
수산화나트륨 | 적당량 | 적당량 | 적당량 | 적당량 | 적당량 |
총량 | 100 ㎖ | 100 ㎖ | 100 ㎖ | 100 ㎖ | 100 ㎖ |
pH | 6.8 | 6.8 | 4.0 | 6.8 | 8.5 |
Claims (11)
- (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산 또는 그의 약리학적으로 허용가능한 산부가염, 및 수용성 금속 염화물을 함유하는 광 안정화된 수성액제(aqueous liquid preparation).
- 제 1 항에 있어서, 금속 염화물의 농도가 0.15 w/v%의 하한 농도 내지 1.5 w/v%의 상한 농도의 범위에서 선택되는 것인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, 금속 염화물이 염화나트륨, 염화칼륨 및 염화칼슘에서 선택된 1종 이상인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산 또는 그의 약리학적으로 허용가능한 산부가염의 농도가 0.1 w/v%의 하한 농도 내지 2.0 w/v%의 상한 농도의 범위에서 선택되는 것인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산의 산부가염인 광 안정화된 수성액제.
- 제 5 항에 있어서, 산부가염이 모노벤젠설포네이트인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, 수성액제의 pH 가 4 - 8.5의 범위인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, 점안제인 광 안정화된 수성액제.
- 제 1 항 또는 제 2 항에 있어서, 점비제인 광 안정화된 수성액제.
- (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산 모노벤젠설포네이트 및 염화나트륨을 0.2 w/v% 이상 0.8 w/v% 이하로 함유하는 광 안정화된 수성 점안제.
- (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산 또는 그의 약리학적으로 허용가능한 산부가염을 함유하는 수용액에 수용성 금속 염화물을 첨가하는 것을 포함하는, 수용액 중의 (+)-(S)-4-[4-[(4-클로로페닐)(2-피리딜)메톡시]피페리디노]부티르산의 광안정화 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002223804 | 2002-07-31 | ||
JPJP-P-2002-00223804 | 2002-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050025137A KR20050025137A (ko) | 2005-03-11 |
KR101016595B1 true KR101016595B1 (ko) | 2011-02-22 |
Family
ID=31184981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047010338A KR101016595B1 (ko) | 2002-07-31 | 2003-07-30 | 수성액제 및 광안정화된 수성액제 |
Country Status (9)
Country | Link |
---|---|
US (3) | US8784789B2 (ko) |
EP (1) | EP1525884B1 (ko) |
JP (1) | JP3631748B2 (ko) |
KR (1) | KR101016595B1 (ko) |
CN (1) | CN1293880C (ko) |
AT (1) | ATE528003T1 (ko) |
AU (1) | AU2003252746A1 (ko) |
ES (1) | ES2371340T3 (ko) |
WO (1) | WO2004011001A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4739340B2 (ja) * | 2005-07-22 | 2011-08-03 | 田辺三菱製薬株式会社 | 口腔内速崩壊性錠 |
BR112013008244A8 (pt) * | 2010-10-06 | 2018-02-14 | Bausch & Lomb | composições de bepotastina |
BR112013017183A2 (pt) * | 2011-01-04 | 2017-07-25 | Bausch & Lomb | composições de bepostatina |
CN104119314B (zh) * | 2013-04-23 | 2018-01-12 | 重庆华邦制药有限公司 | 一种稳定的苯磺酸贝他斯汀晶体及其制备方法 |
CN106038480B (zh) * | 2015-04-16 | 2019-02-22 | 江苏恒瑞医药股份有限公司 | 一种光稳定的水性液体制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998029409A1 (fr) * | 1996-12-26 | 1998-07-09 | Ube Industries, Ltd. | Sels d'addition acides de compose de piperidine optiquement actif et procede de production associe |
JP2001261563A (ja) | 2000-03-16 | 2001-09-26 | Cci Corp | マトリックスメタロプロテアーゼ産生抑制剤 |
WO2001080858A1 (fr) | 2000-04-24 | 2001-11-01 | Daiichi Pharmaceutical Co., Ltd. | Preparation liquide stable |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053628A (en) * | 1971-05-12 | 1977-10-11 | Fisons Limited | Composition |
US4929618A (en) * | 1988-03-25 | 1990-05-29 | Ube Industries, Ltd. | Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same |
US5290774A (en) * | 1989-08-03 | 1994-03-01 | Eisai Co., Ltd. | Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom |
JPH0418015A (ja) * | 1990-05-10 | 1992-01-22 | Fujikawa Kk | 安定なフマル酸クレマスチン水溶液 |
CA2038066A1 (en) * | 1990-08-09 | 1992-02-10 | Hiroshi Fukumi | (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma |
JP3225976B2 (ja) * | 1992-05-29 | 2001-11-05 | キヤノン株式会社 | カラー画像形成装置 |
JP3021312B2 (ja) | 1994-03-15 | 2000-03-15 | 千寿製薬株式会社 | プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤 |
NO950970L (no) * | 1994-03-15 | 1995-09-18 | Senju Pharma Co | Fremgangsmåte for stabilisering av pranoprofen og stabile væskepreparater av pranoprofen |
SE9401109D0 (sv) * | 1994-03-31 | 1994-03-31 | Leiras Oy | Opthalmic composition II |
US5599534A (en) * | 1994-08-09 | 1997-02-04 | University Of Nebraska | Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use |
JP2929274B2 (ja) | 1996-08-15 | 1999-08-03 | エーザイ株式会社 | 点眼液の光安定化方法 |
JP3107784B2 (ja) * | 1996-12-26 | 2000-11-13 | 宇部興産株式会社 | 光学活性ピペリジン誘導体の酸付加塩及びその製法 |
JP3361713B2 (ja) * | 1997-02-26 | 2003-01-07 | 大八化学工業株式会社 | トリブロモネオペンチルリン酸クロロアルキルエステルの製造方法 |
DE69818675T2 (de) * | 1997-07-29 | 2004-07-29 | Alcon Laboratories, Inc., Fort Worth | Galaktomannanpolymere und borat enthaltende augenarzneimittel |
JPH11228404A (ja) | 1997-12-11 | 1999-08-24 | Senju Pharmaceut Co Ltd | 安定な水性点眼剤 |
US6174914B1 (en) | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
US6369001B1 (en) * | 1999-08-11 | 2002-04-09 | Monsanto Technology, Llc | Microemulsion coformulation of a graminicide and a water-soluble herbicide |
PT1225898E (pt) * | 1999-11-01 | 2003-10-31 | Alcon Inc | Composicoes farmaceuticas contendo um farmaco antibiotico de fluoroquinolona e goma xantana |
DE10012732A1 (de) | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
JP3909998B2 (ja) | 2000-03-22 | 2007-04-25 | 田辺製薬株式会社 | 経口投与製剤 |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
CN1293867C (zh) * | 2001-05-25 | 2007-01-10 | 爱诗爱诗制药株式会社 | 药物复合制剂 |
EP2279005A1 (en) | 2008-05-19 | 2011-02-02 | Alcon Research, Ltd. | Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer |
-
2003
- 2003-07-30 AT AT03771445T patent/ATE528003T1/de not_active IP Right Cessation
- 2003-07-30 ES ES03771445T patent/ES2371340T3/es not_active Expired - Lifetime
- 2003-07-30 CN CNB038019035A patent/CN1293880C/zh not_active Expired - Lifetime
- 2003-07-30 AU AU2003252746A patent/AU2003252746A1/en not_active Abandoned
- 2003-07-30 WO PCT/JP2003/009713 patent/WO2004011001A1/ja active Application Filing
- 2003-07-30 KR KR1020047010338A patent/KR101016595B1/ko active IP Right Review Request
- 2003-07-30 EP EP03771445A patent/EP1525884B1/en not_active Expired - Lifetime
- 2003-07-30 US US10/500,354 patent/US8784789B2/en active Active
- 2003-07-30 JP JP2004524320A patent/JP3631748B2/ja not_active Expired - Lifetime
-
2012
- 2012-08-30 US US13/599,212 patent/US8883825B2/en not_active Expired - Lifetime
-
2014
- 2014-10-10 US US14/511,393 patent/US9849121B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998029409A1 (fr) * | 1996-12-26 | 1998-07-09 | Ube Industries, Ltd. | Sels d'addition acides de compose de piperidine optiquement actif et procede de production associe |
JP2001261563A (ja) | 2000-03-16 | 2001-09-26 | Cci Corp | マトリックスメタロプロテアーゼ産生抑制剤 |
WO2001080858A1 (fr) | 2000-04-24 | 2001-11-01 | Daiichi Pharmaceutical Co., Ltd. | Preparation liquide stable |
Also Published As
Publication number | Publication date |
---|---|
AU2003252746A1 (en) | 2004-02-16 |
EP1525884A1 (en) | 2005-04-27 |
CN1612734A (zh) | 2005-05-04 |
US8784789B2 (en) | 2014-07-22 |
WO2004011001A1 (ja) | 2004-02-05 |
KR20050025137A (ko) | 2005-03-11 |
US20150031724A1 (en) | 2015-01-29 |
JPWO2004011001A1 (ja) | 2005-11-24 |
US20120322825A1 (en) | 2012-12-20 |
ATE528003T1 (de) | 2011-10-15 |
US9849121B2 (en) | 2017-12-26 |
JP3631748B2 (ja) | 2005-03-23 |
US20050107429A1 (en) | 2005-05-19 |
EP1525884B1 (en) | 2011-10-12 |
US8883825B2 (en) | 2014-11-11 |
EP1525884A4 (en) | 2007-10-31 |
ES2371340T3 (es) | 2011-12-30 |
CN1293880C (zh) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7875271B2 (en) | Ophthalmic composition comprising xanthan gum and glucose | |
SK147493A3 (en) | Antialergic substances for the use in ophthalmologic and otorhynologic | |
US20170035885A1 (en) | Highly concentrated stable meloxicam solutions | |
US9849121B2 (en) | Aqueous liquid preparations and light-stabilized aqueous liquid preparations | |
EP0938896A1 (en) | Autoclavable pharmaceutical compositions containing a chelating agent | |
EA025414B1 (ru) | Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии | |
JPS62178514A (ja) | 眼局所投与用眼圧降下剤 | |
CA2037057C (en) | Photostabilizing method for ophthalmic solutions and the resulting opthalmic solutions therefrom | |
KR20010012521A (ko) | 방부 조성물 | |
KR100776577B1 (ko) | 점안제 | |
EP0348527B1 (en) | Antiallergic eye drop | |
US6849655B2 (en) | Aqueous liquid formulations | |
US8877168B1 (en) | Aqueous liquid preparations and light-stabilized aqueous liquid preparations | |
KR100776579B1 (ko) | 수성 액제 | |
JP5252846B2 (ja) | 水性医薬組成物 | |
PL172503B1 (pl) | Oftalmiczny srodek do podawania miejscowego zawierajacy pólwodzian (S)-tymololu PL PL PL PL | |
US20180104231A1 (en) | Benzalkonium chloride free ophthalmic composition containing (+)-(s)-4-[4-chlorophenyl) (2-pyridyl) methoxy] piperdino] butyric acid or pharmacologically acceptable acid addition salt, thereof | |
EP0842658B1 (en) | Photostable aqueous solution containing benzyl alcohol derivatives | |
JP3232503B2 (ja) | 光に安定なベンジルアルコール誘導体含有水溶液 | |
JP2012224630A (ja) | ペミロラストを含有する安定な水性組成物 | |
JPH0338251B2 (ko) | ||
JPH04134029A (ja) | 緑内障治療剤 | |
CA2621616A1 (en) | Topical gatifloxacin formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
J202 | Request for trial for correction [limitation] | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR CORRECTION REQUESTED 20130215 Effective date: 20130423 |
|
FPAY | Annual fee payment |
Payment date: 20140205 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150122 Year of fee payment: 5 |
|
J204 | Request for invalidation trial [patent] | ||
J121 | Written withdrawal of request for trial | ||
J204 | Request for invalidation trial [patent] | ||
J121 | Written withdrawal of request for trial | ||
J501 | Disposition of invalidation of trial | ||
J121 | Written withdrawal of request for trial | ||
J501 | Disposition of invalidation of trial | ||
J501 | Disposition of invalidation of trial | ||
J121 | Written withdrawal of request for trial | ||
J121 | Written withdrawal of request for trial | ||
J501 | Disposition of invalidation of trial | ||
J121 | Written withdrawal of request for trial | ||
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161222 Year of fee payment: 7 |
|
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015100002346; TRIAL DECISION FOR INVALIDATION REQUESTED 20150410 Effective date: 20171026 Free format text: TRIAL NUMBER: 2015100002353; TRIAL DECISION FOR INVALIDATION REQUESTED 20150410 Effective date: 20171026 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200129 Year of fee payment: 10 |